National Institute for Health and Care Excellence5d
In consultation: Guidance and quality standards
Pembrolizumab with carboplatin and paclitaxel for untreated advanced or recurrent endometrial cancer [ID6381] Draft guidance Technology appraisal guidance 14 April 2025 Natalizumab (originator and ...
National Institute for Health and Care Excellence9d
NICE Health Technology Assessment training programme
have completed their Master of Public health (MPH) or individuals undertaking the portfolio route must have either passed their DFPH (Faculty of Public Health Diplomate Examination, formally Part A ...